Researchers conducted interviews to gather the perspectives of both clinicians and nurses. Researchers conducted a cross-sectional survey of patients with multiple myeloma to address the question. Dr. Richter discusses the data he presented during the 20th IMS Annual Meeting Exposition. Researchers evaluated 1,704 patients with triple-class exposure, including 1,072 who had four-plus previous lines of therapy.